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Abstract
© 2016 American Heart Association, Inc. Objective - Obstructive thrombi or thrombotic emboli
are the pathogenic basis of ischemic stroke. In vitro blood clots and in vivo thrombi can undergo
platelet-driven  contraction  (retraction),  resulting  in  volume shrinkage.  Clot  contraction  can
potentially reduce vessel occlusion and improve blood flow past emboli or thrombi. The aim of
this work was to examine a potential pathogenic role of clot contraction in ischemic stroke.
Approach and Results - We used a novel automated method that enabled us to quantify time of
initiation and extent and rate of clot contraction in vitro. The main finding is that clot contraction
from the blood of stroke patients was reduced compared with healthy subjects. Reduced clot
contraction  correlated  with  a  lower  platelet  count  and  their  dysfunction,  higher  levels  of
fibrinogen and hematocrit, leukocytosis, and other changes in blood composition that may affect
platelet function and properties of blood clots. Platelets from stroke patents were spontaneously
activated and displayed reduced responsiveness to additional stimulation. Clinical correlations
with respect to severity and stroke pathogenesis suggest that the impaired clot contraction has
the potential to be a pathogenic factor in ischemic stroke. Conclusions - The changeable ability
of  clots  and thrombi  to  shrink  in  volume may be a  novel  unappreciated mechanism that
aggravates or alleviates the course and outcomes of ischemic stroke. The clinical importance of
clot or thrombus transformations in vivo and the diagnostic and prognostic value of this blood
test for clot contraction need further exploration.
http://dx.doi.org/10.1161/ATVBAHA.116.308622
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